ALTO Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
257.9M
+5.0%
245.7M
+9.4%
224.7M
-3.1%
232.0M
-3.7%
241.0M
Cost of Revenue
243.1M
+6.1%
229.1M
+6.3%
215.5M
-0.6%
216.8M
-0.3%
217.5M
Gross Profit
14.8M
-11.0%
16.6M
+80.5%
9.2M
-39.2%
15.2M
-35.5%
23.5M
Operating Expenses
7.8M
-2.9%
8.0M
+19.7%
6.7M
-12.7%
7.7M
+17.8%
6.5M
R&D
0
0
0
0
0
SG&A
7.8M
-2.9%
8.0M
+19.7%
6.7M
-8.6%
7.3M
+12.6%
6.5M
Operating Income
7.0M
-18.6%
8.6M
+242.0%
2.5M
-66.3%
7.5M
-55.9%
17.0M
EBITDA
14.0M
-8.9%
15.3M
+67.8%
9.1M
-36.6%
14.4M
-38.7%
23.5M
Net Income
13.0M
+11.3%
11.7M
+174.0%
4.3M
-80.4%
21.8M
+53.5%
14.2M
EPS (Basic)
$0.17
+13.3%
$0.15
+200.0%
$0.05
-82.8%
$0.29
+52.6%
$0.19
EPS (Diluted)
$0.16
+6.7%
$0.15
+200.0%
$0.05
-81.5%
$0.27
+42.1%
$0.19
Shares (Diluted)
77.6M
+0.7%
77.1M
+3.1%
74.8M
-5.8%
79.4M
+6.2%
74.8M
Alto Ingredients (ALTO) — Financials